OS Therapies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OS Therapies Incorporated on October 14, 2025. The report addresses the adjournment of the Company's 2025 Annual Meeting of Stockholders and the disclosure of an investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes and Events
- Annual Meeting Adjournment: The 2025 Annual Meeting, convened on October 14, 2025, was adjourned to allow additional time to solicit proxies.
- Voting Status: Preliminary tabulations indicated that the Issuance Proposal, Charter Amendment Proposal, and Auditor Ratification Proposal received the requisite votes for approval.
- Reconvened Meeting: The meeting will reconvene virtually on October 21, 2025, at 10:00 a.m. Eastern time.
- Record Date: The record date for stockholders entitled to vote remains August 20, 2025.
Guidance, Outlook, and Disclosures
- Investor Presentation: On October 17, 2025, the Company posted an investor presentation to its website (ir.ostherapies.com), furnished as Exhibit 99.1. This information is not incorporated by reference into this 8-K.
- Solicitation: The Company will continue to solicit votes from stockholders during the adjournment period. Stockholders who have already voted do not need to take action unless they wish to change their vote.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Key Facts for Investor Verification
- Verify the final vote count for the Issuance, Charter Amendment, and Auditor Ratification proposals at the reconvened meeting on October 21, 2025.
- Review the Investor Presentation (Exhibit 99.1) for strategic updates, noting it is not legally "filed" under Section 18 of the Exchange Act.
- Confirm the record date of August 20, 2025, to ensure eligibility to vote at the reconvened meeting.
- Check the definitive Proxy Statement filed on August 25, 2025, for detailed descriptions of the proposals.